Diagnosis and management of cervical cancer

British Medical Journal

Volumn 335, Issue 7623, 2007, Pages 765-768

  Petignat, Patrick ^a   Roy, Michel ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ADENOSQUAMOUS CARCINOMA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CLINICAL FEATURE; CLINICAL TRIAL; COLPOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE FERTILITY; HISTOPATHOLOGY; HUMAN; LAPAROSCOPY; LAPAROTOMY; LYMPH NODE BIOPSY; META ANALYSIS; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADICAL HYSTERECTOMY; RECURRENT CANCER; REVIEW; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; SYMPTOM; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; TUMOR BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VAGINA DISCHARGE; WART VIRUS;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; FEMALE; HUMANS; INFERTILITY, FEMALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PALLIATIVE CARE; RADIOTHERAPY, ADJUVANT; SENTINEL LYMPH NODE BIOPSY; UTERINE CERVICAL NEOPLASMS;

EID: 35449002070     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39337.615197.80     Document Type: Review

References (25)

1. World Health Organization. Comprehensive cervical cancer control. A guide to essential practice. Geneva: WHO, 2006.
2. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-40.
3. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53.
4. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339-48.
5. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001;358:781-6.
6. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
7. Creasman WT. New gynecologic cancer staging. Gynecol Oncol 1995;58:157-8.
8. Hricak H, Gatsonis C, Chi DS, Amendola MA, Brandt K, Schwartz LH, etal. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 2005;23:9329-37.
9. Sironi, S, Buda A, Picchio M, Perego P, Moreni R, Pellegrino A, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 2005;238:272-9.
10. Lai CH, Huang KG, Hong JH, Lee CL, Chou HH, Chang TC, et al. Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol 2003;89:160-7.
11. Weiser EB, Bundy BN, Hoskins WJ, Heller PB, Whittington RR, DiSaia PJ, et al. Extraperitoneal versus transperitoneal selective paraaortic lymphadenectomy in the pretreatment surgical staging of advanced cervical carcinoma (a Gynecologic Oncology Group study). Gynecol Oncol 1989;33:283-9.
12. Vasilev SA, McGonigle KF. Extraperitoneal laparoscopic para-aortic lymph node dissection. Gynecol Oncol 1996;61:315-20.
13. Lagasse LD, Creasman WT, Shingleton HM, Ford JH, Blessing JA. Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol Oncol 1980:9:90-8.
14. Narayan K. Arguments for a magnetic resonance imaging-assisted FIGO staging system for cervical cancer. Int J Gynecol Cancer 2005;15:573-82.
15. Bekkers RLM, Keyser KGG, Bulten J, Hanselaar AGJM, Schijf CPT, Boonstra H, et al. The value of loop electrosurgical conization in the treatment of stage IA1 microinvasive carcinoma of the uterine cervix. Int J Gynecol Cancer 2002;12:485-9.
16. Sonoda Y, Abu-Rustum NR, Gemignani ML, Chi DS, Brown CL, Poynor EA, et al. A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible? Gynecol Oncol 2004;95:534-8.
17. Plante M, Renaud MC, Roy M. Radical vaginal trachelectomy: a fertility-preserving option for young women with early stage cervical cancer. Gynecol Oncol 2005:99(3 suppl 1):S143-6.
18. Plante M, Renaud MC, Tetu B, Harel F, Roy M. Laparoscopic sentinel node mapping in early-stage cervical cancer. Gynecol Oncol 2003;91:494-503.
19. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-61.
20. Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, et al. A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Intl Radiat Oncol Biol Phys 2006;65:169-76.
21. Peters WA III, Liu PY, Barrett RJ II, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-13.
22. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-43.
23. Monk BJ, Huang HQ, Cella D, Long HJ III. Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2005;23:4617-25.
24. Medical Practice and Ethics Committee. Practice guidelines: cervical cancer. Society of Gynecologic Oncologists Medical Practice Ethics Committee. Oncology (Williston Park). 1998;12:134-8.
25. Dreyer G, Snyman LC, Mouton A, Lindeque BG. Management of recurrent cervical cancer. Best Pract Res Clin Obstet Gynaecol 2005;19:631-44.